Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT05296980
Recruiting Not applicable

Validation of the REMINDER Dementia Risk Reduction Program

NCT05296980 · tracked via the Priya Life Science Portugal tracker
Phase
Not applicable
Started
2022-04-01
Last updated
2024-05-08

Condition(s) studied

Healthy AgingRisk ReductionOld Age; Dementia

Investigational drug(s) / intervention(s)

REMINDERBrain health Psychoeducation

REMINDER: The REMINDER program is a therapist-mediated manualized neuropsychological intervention, involving training skills to stimulate cognitive reserve, socialization and personal development, to diminish the risk of cognitive decline.

Brain health Psychoeducation: Delivery of psychoeducation sessions about dementia modifiable risk factors, brain health solutions and lifestyle change tips.

Study summary

Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some RCTs have been developed in cognitive training interventions, comparative studies of merged interventions (cognitive, social and behavioral stimulation) with adequate control groups are absent, diminishing the professionals' trust on the adoption of these interventions for supporting patients. As such, the present proposal will develop a validation trial testing a multicomponent neuropsychological intervention (REMINDER), based on personal development, cognitive compensatory aids, meaningful goals setting, and behavior change techniques. The investigators will analyze its short/long-term gains and AD conversion rates. By aiming to provide a good validation study for REMINDER, the investigators will examine neurobiological, neurocognitive and functional outcomes of this intervention in comparison with an active control group (psychoeducation) in order to foster an effective outcome assessment of an intervention for individuals at risk of AD.

Eligibility

Sex
ALL
Min age
60 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 60 or older * CAIDE dementia risk score \>8 * Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED * Free of physical disabilities that preclude participation in the study * Willing to complete all study-related activities for 12 weeks Exclusion Criteria: * Mild cognitive impairment or dementia; * Presence of any neurological event in their medical history that could compromise actual cognition. * Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria). * Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group. * Illiteracy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Psychology and Educational Sciences Coimbra Portugal Recruiting

More University of Coimbra trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05296980 on ClinicalTrials.gov ↗ ← All trials in Portugal